COVID-19, hyperglycemia, and new-onset diabetes

K Khunti, S Del Prato, C Mathieu, SE Kahn… - Diabetes …, 2021 - diabetesjournals.org
Certain chronic comorbidities, including diabetes, are highly prevalent in people with
coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe …

Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020

ВБ Гриневич, ИВ Губонина, ВЛ Дощицин… - Кардиоваскулярная …, 2020 - cyberleninka.ru
Пандемия новой коронавирусной инфекции (COVID19), распространяемая вирусом
SARS-CoV-2, стала вызовом системам здравоохранения всех стран мира …

Сахарный диабет и COVID-19: анализ клинических исходов по данным регистра сахарного диабета Российской Федерации

МВ Шестакова, ОК Викулова, МА Исаков… - Проблемы …, 2020 - cyberleninka.ru
ОБОСНОВАНИЕ. Мировые и отечественные данные свидетельствуют о более
высокой смертности пациентов с сахарным диабетом (СД) вследствие COVID-19, что …

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection

L Montefusco, M Ben Nasr, F D'Addio, C Loretelli… - Nature …, 2021 - nature.com
Patients with coronavirus disease 2019 (COVID-19) are reported to have a greater
prevalence of hyperglycaemia. Cytokine release as a consequence of severe acute …

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …

[HTML][HTML] Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes

L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei… - Cell metabolism, 2020 - cell.com
Summary Type 2 diabetes (T2D) is a major comorbidity of COVID-19. However, the impact of
blood glucose (BG) control on the degree of required medical interventions and on mortality …

[HTML][HTML] Global pandemics interconnected—obesity, impaired metabolic health and COVID-19

N Stefan, AL Birkenfeld, MB Schulze - Nature Reviews Endocrinology, 2021 - nature.com
Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …

The Stanford Hall consensus statement for post-COVID-19 rehabilitation

RM Barker-Davies, O O'Sullivan… - British journal of sports …, 2020 - bjsm.bmj.com
The highly infectious and pathogenic novel coronavirus (CoV), severe acute respiratory
syndrome (SARS)-CoV-2, has emerged causing a global pandemic. Although COVID-19 …